Pharmaceutical industry – Page 57
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
News
FDA green lights new obesity drug
Agency approval for prescription only obesity drug is first for 13 years
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Roche cuts 1000 jobs with US R&D site closure
Streamlining strategy will see oncology and virology research moved to Switzerland and Germany
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
Business
Lundbeck to lose 600 jobs
Danish drug maker Lundbeck has said it will cut 600 jobs as it reorganises its European operations
-
Business
Good signs for Merck & Co insomnia pill
Suvorexant switches off wakefulness to help patients drop off quicker and stay asleep longer
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US
-
Business
Three pronged approach puts brakes on US breast cancer
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer
-
Business
Pfizer to spin off animal health business
New company Zoetis should start independent trading by July 2013
-
-
News€224 million EU antibiotics initiative launched
The project will bring together the pharmaceutical industry and academia, but some institutes have reservations
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products
-
BusinessHDL drug class struggling after latest flop
The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
-
BusinessDrug watchdogs mark out global territory
US and European regulatory agencies are leading worldwide collaborations to ensure drugs from outside their borders are safe
-
News
Pharma firms see mixed fortunes in Quebec
Canada’s pharmaceutical and life sciences hub hit by cutbacks as effects of global slowdown continue to be felt
-
News
Ranbaxy launches new anti-malarial Synriam
India is still waiting for its first fully home grown drug as firm commercialises molecule discovered by charitable venture
-
BusinessAstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues